491 related articles for article (PubMed ID: 34057379)
21. A Cloud-based Framework for Implementing Portable Machine Learning Pipelines for Neural Data Analysis.
Ellis CA; Gu P; Sendi MSE; Huddleston D; Sharma A; Mahmoudi B
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():4466-4469. PubMed ID: 31946857
[TBL] [Abstract][Full Text] [Related]
22. Use of cloud computing in biomedicine.
Sobeslav V; Maresova P; Krejcar O; Franca TC; Kuca K
J Biomol Struct Dyn; 2016 Dec; 34(12):2688-2697. PubMed ID: 26646249
[TBL] [Abstract][Full Text] [Related]
23. Critical assessment of AI in drug discovery.
Walters WP; Barzilay R
Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
[No Abstract] [Full Text] [Related]
24. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
Huang DZ; Baber JC; Bahmanyar SS
Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
[TBL] [Abstract][Full Text] [Related]
25. Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.
Raschka S; Kaufman B
Methods; 2020 Aug; 180():89-110. PubMed ID: 32645448
[TBL] [Abstract][Full Text] [Related]
26. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
Zhang L; Tan J; Han D; Zhu H
Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
[TBL] [Abstract][Full Text] [Related]
27. Open data and algorithms for open science in AI-driven molecular informatics.
Brinkhaus HO; Rajan K; Schaub J; Zielesny A; Steinbeck C
Curr Opin Struct Biol; 2023 Apr; 79():102542. PubMed ID: 36805192
[TBL] [Abstract][Full Text] [Related]
28. Advances in distributed computing with modern drug discovery.
Banegas-Luna AJ; Imbernón B; Llanes Castro A; Pérez-Garrido A; Cerón-Carrasco JP; Gesing S; Merelli I; D'Agostino D; Pérez-Sánchez H
Expert Opin Drug Discov; 2019 Jan; 14(1):9-22. PubMed ID: 30484337
[TBL] [Abstract][Full Text] [Related]
29. Browser-based Data Annotation, Active Learning, and Real-Time Distribution of Artificial Intelligence Models: From Tumor Tissue Microarrays to COVID-19 Radiology.
Bhawsar PMS; Abubakar M; Schmidt MK; Camp NJ; Cessna MH; Duggan MA; García-Closas M; Almeida JS
J Pathol Inform; 2021; 12():38. PubMed ID: 34760334
[TBL] [Abstract][Full Text] [Related]
30. Enhancing preclinical drug discovery with artificial intelligence.
Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
[TBL] [Abstract][Full Text] [Related]
31. How can artificial intelligence be used for peptidomics?
Perpetuo L; Klein J; Ferreira R; Guedes S; Amado F; Leite-Moreira A; Silva AMS; Thongboonkerd V; Vitorino R
Expert Rev Proteomics; 2021 Jul; 18(7):527-556. PubMed ID: 34343059
[TBL] [Abstract][Full Text] [Related]
32. A Cloud Enabled Crop Recommendation Platform for Machine Learning-Driven Precision Farming.
Thilakarathne NN; Bakar MSA; Abas PE; Yassin H
Sensors (Basel); 2022 Aug; 22(16):. PubMed ID: 36016060
[TBL] [Abstract][Full Text] [Related]
33. Internet of Things in Space: A Review of Opportunities and Challenges from Satellite-Aided Computing to Digitally-Enhanced Space Living.
Kua J; Loke SW; Arora C; Fernando N; Ranaweera C
Sensors (Basel); 2021 Dec; 21(23):. PubMed ID: 34884122
[TBL] [Abstract][Full Text] [Related]
34. Pangea: An MLOps Tool for Automatically Generating Infrastructure and Deploying Analytic Pipelines in Edge, Fog and Cloud Layers.
Miñón R; Diaz-de-Arcaya J; Torre-Bastida AI; Hartlieb P
Sensors (Basel); 2022 Jun; 22(12):. PubMed ID: 35746207
[TBL] [Abstract][Full Text] [Related]
35. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
[TBL] [Abstract][Full Text] [Related]
36. PhenoMeNal: processing and analysis of metabolomics data in the cloud.
Peters K; Bradbury J; Bergmann S; Capuccini M; Cascante M; de Atauri P; Ebbels TMD; Foguet C; Glen R; Gonzalez-Beltran A; Günther UL; Handakas E; Hankemeier T; Haug K; Herman S; Holub P; Izzo M; Jacob D; Johnson D; Jourdan F; Kale N; Karaman I; Khalili B; Emami Khonsari P; Kultima K; Lampa S; Larsson A; Ludwig C; Moreno P; Neumann S; Novella JA; O'Donovan C; Pearce JTM; Peluso A; Piras ME; Pireddu L; Reed MAC; Rocca-Serra P; Roger P; Rosato A; Rueedi R; Ruttkies C; Sadawi N; Salek RM; Sansone SA; Selivanov V; Spjuth O; Schober D; Thévenot EA; Tomasoni M; van Rijswijk M; van Vliet M; Viant MR; Weber RJM; Zanetti G; Steinbeck C
Gigascience; 2019 Feb; 8(2):. PubMed ID: 30535405
[TBL] [Abstract][Full Text] [Related]
37. New avenues in artificial-intelligence-assisted drug discovery.
Cerchia C; Lavecchia A
Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
[TBL] [Abstract][Full Text] [Related]
38. Artificial Intelligence, Machine Learning, Deep Learning, and Cognitive Computing: What Do These Terms Mean and How Will They Impact Health Care?
Bini SA
J Arthroplasty; 2018 Aug; 33(8):2358-2361. PubMed ID: 29656964
[TBL] [Abstract][Full Text] [Related]
39. Edge-Computing and Machine-Learning-Based Framework for Software Sensor Development.
Hanzelik PP; Kummer A; Abonyi J
Sensors (Basel); 2022 Jun; 22(11):. PubMed ID: 35684889
[TBL] [Abstract][Full Text] [Related]
40. Drug Intelligence Science (DIS®): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development.
Schweizer L
Drug Discov Today; 2023 Nov; 28(11):103795. PubMed ID: 37805064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
